Medial-prefrontal Enhancement During Schizophrenia Systems Imaging
RecruitingNCT04807530Phase: NAStarted 2020-11-12
Summary
This randomized controlled trial in healthy controls (HC) and patients with schizophrenia (SZ) aims to examine 1) the underlying cognitive and neural cause of self-agency deficits in SZ; 2) the respon
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
64 Years
Locations
UCSFSan Francisco, California, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT04807530